We use our GCBase (Core Capability of GenomiCare) to transform drug discovery 

Our discoveries help create better cancer medicines faster

Original Drug Discovery

Based on patient-centric real-world data, through a systematic AI approach by integrating

real-world knowledge and clear disease mechanisms


GCInsight is a powerful tool to help researchers and drug developers understand the distribution of genetic or clinical markers across various types of cancers, and quickly identify indicators with potential clinical value

Customized Service to Bring Cutting Edge Solutions

GenomiCare Biotechnology joins the Roche Accelerator

Shanghai,June 8th, 2022 - GenomiCare Biotechnology (Shanghai) Co., Ltd. (hereinafter referred to as GenomiCare Biotechnology) announces acceptance by the Roche Accelerator. With the support from Roche Accelerator, GenomiCare Biotechnology will further devote...

Highlights from ISPOR (Real World China)

GenomiCare’s sponsored ISPOR Webinar featured a cast of experts from Novartis, Roche, and AstraZeneca in a engaging  discussion about Real World Evidence in China. Key takeaways included: On the data, itself: Representativeness and Quality of data is paramount Overall...

ISPOR Webinar- China RWE/RWD

On June 29th, GenomiCare Biotechnology hosted an ISPOR webinar about the opportunities/challenges of RWE/RWD collection from China.